{"id":"W2949365580","doi":"10.1007/s00277-019-03747-2","title":"Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A","year":2019,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Impact; McMaster University","funders":"Chugai Pharmaceutical; LEO Pharma; Grifols; Daiichi Sankyo Europe; Sanofi; Bayer HealthCare; Swedish Orphan Biovitrum; Baxalta; CSL Behring; Biogen; Novo Nordisk; Alnylam Pharmaceuticals; Pfizer","keywords":"Medicine; Crossover study; Confidence interval; Pharmacokinetics; Adverse effect; Randomized controlled trial; Population; Half-life; Internal medicine; Gastroenterology; Placebo","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005958606,0.0002641197,0.002248432,0.0003306279,0.00002844974,0.00000551998,0.0001640718,0.00008723995,0.0001969693],"category_scores_gemma":[0.0003684032,0.0001683857,0.0001432638,0.0004512614,0.0002617116,0.00007969322,0.00009051088,0.000245407,0.00003409451],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001577622,"about_ca_system_score_gemma":0.0001910981,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001642019,"about_ca_topic_score_gemma":0.00001651012,"domain_scores_codex":[0.9972292,0.0003770764,0.0008991421,0.0004798936,0.0005454457,0.0004692975],"domain_scores_gemma":[0.9982162,0.0003449854,0.0003468699,0.0005257449,0.0004311511,0.00013503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1054137,0.009834382,0.880996,0.0006538953,0.0006596554,0.00005763492,0.0009490413,0.00001669485,0.0001921368,0.0001214507,0.0006366454,0.0004687835],"study_design_scores_gemma":[0.7059347,0.008982744,0.2339884,0.0008519422,0.0004520031,0.00006294747,0.0006062067,0.0003216994,0.04789793,0.000217897,0.0002151826,0.0004683847],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915071,0.0009348718,7.131861e-7,0.001387494,0.0001367341,0.004093238,0.000006849945,0.00001983639,0.001913236],"genre_scores_gemma":[0.9990864,0.00005717128,0.0000782703,0.00009592979,0.00001513498,0.00009085561,0.00002688576,0.00002947499,0.000519853],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6470076,"threshold_uncertainty_score":0.686657,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04433606071016476,"score_gpt":0.382986038400816,"score_spread":0.3386499776906512,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}